The FDA granted Incyte, a Wilmington, Del.-based pharmaceutical company, the first approval for a vitiligo treatment after finding positive results in its phase 3 trials July 18.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves 1st at-home treatment for vitiligo
